Fundz

ProteinQure

Toronto, Ontario, Canada · Biotechnology, Health Care, Therapeutics

ProteinQure is a biotechnology company developing computational peptide therapeutics. They focus on designing therapeutic peptides using a proprietary platform that combines machine learning, structural biology, and atomic-level simulations. Their innovations aim to enable tissue-specific delivery and access to novel target classes in various medical fields such as oncology and neurology. The comp

Key facts

Headquarters
Toronto, Ontario, Canada
Employees
32
Industries
Biotechnology, Health Care, Therapeutics
Status
Private
Website
www.proteinqure.com
LinkedIn
Company page

Recent activity at ProteinQure

ProteinQure funding history

DateRoundAmount
May 2025Series A$11.0M

Leadership

  • David White, Head Of Drug Discovery
  • Tomas Babej, Founder
  • Mark Fingerhuth, Founder
  • Christopher Ing, Founder
  • Lucas Siow, Founder

Verified email and direct lines for ProteinQure’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

ProteinQure in the news

Companies similar to ProteinQure

About ProteinQure: questions and answers

What does ProteinQure do?

ProteinQure is a biotechnology company developing computational peptide therapeutics. They focus on designing therapeutic peptides using a proprietary platform that combines machine learning, structural biology, and atomic-level simulations. Their innovations aim to enable tissue-specific delivery and access to novel target classes in various medical fields such as oncology and neurology. The comp

Where is ProteinQure headquartered?

ProteinQure is headquartered in Toronto, Ontario, Canada.

How many employees does ProteinQure have?

ProteinQure has about 32 employees.

Has ProteinQure raised funding?

Yes. Fundz has recorded 1 funding event for ProteinQure. The most recent, Series A of $11.0M, was in May 2025.

Who leads ProteinQure?

Tomas Babej is a Founder at ProteinQure.

What is the latest news on ProteinQure?

On May 28, 2025, ProteinQure raises $11M in Series A funding, led by Tom Williams of Heron Rock Fund, to support its first clinical trial for PQ203 and advance pipeline programs.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches ProteinQure across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.